Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 319863011000036111 | sodium tetradecyl sulfate 150 mg / 5 mL injection, 10 x 5 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 319865011000036112 | sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, 10 x 5 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, 10 x 5 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, 10 x 5 mL vials | has MPUU | sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fibro-Vein 3% (150 mg/5 mL) injection, 10 x 5 mL vials | Is a | True | sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, 10 x 5 mL vials | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR